Literature DB >> 4355423

Fibrinolysis associated with oncogenic transformation. Requirement of plasminogen for correlated changes in cellular morphology, colony formation in agar, and cell migration.

L Ossowski, J P Quigley, G M Kellerman, E Reich.   

Abstract

Fetal bovine and dog serum were selectively freed of plasminogen by affinity chromatography. The resulting serum as well as native and reconstituted serum (obtained by the addition of purified plasminogen to the plasminogen-depleted serum) were used to examine the role of plasminogen in (a) growth of normal and SV-40-transformed hamster embryo fibroblasts in liquid medium, (b) growth of SV-40-transformed hamster embryo fibroblasts in soft agar, (c) aggregation - a characteristic morphological change of SV-40-transformed hamster cells, and (d) migration of SV-40-transformed and control 3T3 cells from a monolayer into a "wound." The results demonstrated that exponential growth of both normal and transformed cells in liquid medium proceeded at the same rate in the presence or absence of plasminogen. In contrast, removal of plasminogen markedly depressed the plating efficiency of transformed cells in soft agar, eliminated their characteristic aggregation, and substantially reduced the extent of migration. The role of plasminogen and its activation in oncogenic transformation is discussed.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4355423      PMCID: PMC2139430          DOI: 10.1084/jem.138.5.1056

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  6 in total

1.  Requirement of serum for DNA synthesis in BHK 21 cells: effects of density, suspension and virus transformation.

Authors:  G D Clarke; M G Stoker; A Ludlow; M Thornton
Journal:  Nature       Date:  1970-08-22       Impact factor: 49.962

2.  A factor from a transformed cell line that affects cell migration.

Authors:  R R Bürk
Journal:  Proc Natl Acad Sci U S A       Date:  1973-02       Impact factor: 11.205

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Plasminogen: purification from human plasma by affinity chromatography.

Authors:  D G Deutsch; E T Mertz
Journal:  Science       Date:  1970-12-04       Impact factor: 47.728

5.  An enzymatic function associated with transformation of fibroblasts by oncogenic viruses. I. Chick embryo fibroblast cultures transformed by avian RNA tumor viruses.

Authors:  J C Unkeless; A Tobia; L Ossowski; J P Quigley; D B Rifkin; E Reich
Journal:  J Exp Med       Date:  1973-01-01       Impact factor: 14.307

6.  An enzymatic function associated with transformation of fibroblasts by oncogenic viruses. II. Mammalian fibroblast cultures transformed by DNA and RNA tumor viruses.

Authors:  L Ossowski; J C Unkeless; A Tobia; J P Quigley; D B Rifkin; E Reich
Journal:  J Exp Med       Date:  1973-01-01       Impact factor: 14.307

  6 in total
  44 in total

1.  Identification of a plasminogen activator derived from nasopharyngeal carcinoma.

Authors:  T Kosugi; G W Huang; M Nakamura; S Koja; H T Nong
Journal:  Eur Arch Otorhinolaryngol       Date:  1990       Impact factor: 2.503

2.  The resistance of certain tissues to invasion. III. Cartilage extracts inhibit the growth of fibroblasts and endothelial cells in culture.

Authors:  R Eisenstein; K E Kuettner; C Neapolitan; L W Soble; N Sorgente
Journal:  Am J Pathol       Date:  1975-11       Impact factor: 4.307

3.  Plasminogen-independent fibrinolysis by proteases produced by transformed chick embryo fibroblasts.

Authors:  L B Chen; J M Buchanan
Journal:  Proc Natl Acad Sci U S A       Date:  1975-03       Impact factor: 11.205

4.  Phenotypes of Rous sarcoma virus-transformed fibroblasts: an argument for a multifunctional Src gene product.

Authors:  R R Friis; R T Schwarz; M F Schmidt
Journal:  Med Microbiol Immunol       Date:  1977       Impact factor: 3.402

5.  Proteolytic enzymes and arachidonic acid metabolites produced by MRC-5 cells on various microcarrier substrates.

Authors:  J Varani; J D Hasday; R G Sitrin; P G Brubaker; W A Hillegas
Journal:  In Vitro Cell Dev Biol       Date:  1986-10

6.  Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes.

Authors:  M P Stoppelli; A Corti; A Soffientini; G Cassani; F Blasi; R K Assoian
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

7.  Occult pancreatic cancer with recurrent acute pancreatitis.

Authors:  C Wilson; C W Imrie
Journal:  Postgrad Med J       Date:  1986-08       Impact factor: 2.401

8.  Protease effects on specific growth properties of normal and transformed baby hamster kidney cells.

Authors:  M Brown; D Kiehn
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

9.  Modulation of cell-associated plasminogen activator activity by cocultivation of a stem cell and its tumorigenic descendant.

Authors:  H Y Liu; P P Yang; D L Toledo; W F Mangel
Journal:  Mol Cell Biol       Date:  1984-01       Impact factor: 4.272

10.  Cell associated urokinase activity and colonic epithelial cells in health and disease.

Authors:  P R Gibson; E van de Pol; W F Doe
Journal:  Gut       Date:  1991-02       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.